Everolimus Use for Intolerance or Failure of Baseline Immunosuppression in Adult Heart and Lung Transplantation

BACKGROUND: Everolimus can be utilized after heart or lung transplantation to reduce calcineurin inhibitor associated nephrotoxicity, due to cell cycle inhibitor adverse effects, and as adjunct therapy for rejection, cardiac allograft vasculopathy, and bronchiolitis obliterans syndrome. MATERIAL/MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelsh, Shelby E., Girgis, Reda, Dickinson, Michael, McDermott, Jennifer K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248067/
https://www.ncbi.nlm.nih.gov/pubmed/30348935
http://dx.doi.org/10.12659/AOT.910952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248067/
https://www.ncbi.nlm.nih.gov/pubmed/30348935
http://dx.doi.org/10.12659/AOT.910952

Ejemplares similares